SIGA Technologies Inc. (SIGA)
Symbol Info
Listed Symbol SIGA
Name SIGA Technologies Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $477,053,782
Latest Fiscal EPS $5.12
Price Info
21 Day Moving Average $5.4229
21 Day EMA $5.373950
50 Day Moving Average $5.2830
50 Day EMA $5.371960
200 Day EMA $5.660080
200 Day Moving Average 5.875350
52 Week High $8.09
52 Week Low $4.68
52 Week Change $8.039200
Alpha 0.048073
Beta 0.6271
Standard Deviation 0.277738
R2 0.006019
Periods 60
Share Information
10 Day Average Volume 133,547
20 Day Average Volume 155,387
30 Day Average Volume 146,941
50 Day Average Volume 132,245
Outstanding Shares 81,046,524
Float Shares 76,673,884
Percent Float 94.60%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 228
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 3,009,090
Institute Holdings Percent 38.300000
Institute Sold Previous 3 Months 1,025,371
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 6
Insider Holdings Percent 5.40%
Insider Sold Previous 3 Months -
Insiders Shares Owned 4,372,640
Price Change
7 Day Price Change $0.2600002
7 Day Percent Change 4.95%
21 Day Price Change $-0.04
21 Day Percent Change -0.72%
30 Day Price Change $-0.1599999
30 Day Percent Change -2.82%
Month To Date Price Change $0.3900
Month To Date Percent 7.62%
90 Day Price Change $-0.22
90 Day Percent Change -3.84%
Quarter To Date $0.390000
Quarter To Date Percent 7.62%
180 Day Price Change $0.060000
180 Day Percent Change 1.10%
200 Day Price Change $-0.15
200 Day Percent Change -2.65%
Year To Date $-2.39
Year To Date Percent -30.25%
Profile
Description SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by the variola virus. Its products target orthopoxvirus infections including smallpox.
Details
Issue Type CS
Market Cap $446,566,347
Sec Type EQS
Auditor PricewaterhouseCoopers LLP
Total Shares Outstanding 81,046,524
CEO Phillip Louis Gomez
Employees 41
Last Audit UE
Classification
CIK 0001010086
Industry Biotechnology
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 27 East 62nd Street
New York, NY 10065
Website http://www.siga.com
Facisimile +1 212 697-3130
Telephone +1 212 672-9100
Email
Key Ratios
Profitability
EBIT Margin 91.20
EBITDA Margin 91.2
Pre-Tax Profit Margin -1,543.5
Profit Margin Cont -
Gross Margin 77.60
Profit Margin TOT -
Income Statements
Revenue $15,936,003
Revenue Per Share $0.1966
Revenue 3 Years $86.59
Revenue 5 Years $96.61
Valuation Measures
PE Ratio 1.00
Enterprise Value $392,877,279
Price To Sales 28.022484
Price To Free Cash -52.1
PE High Last 5 Years -
Price To Book 4.0
Price To Cash Flow 5.5
PE Low Last 5 Years -
Price To Tangible Book 4.1
Financial Strength
Total Debt To Equity 0.8
Int Coverage 28.1
Current Ratio 10.9
Leverage Ratio 1.8
Quick Ratio 9.4
Long Term Debt To Capital 0.43
Assets
Receivables Turnover 2.9
Invoice Turnover 41.10
Assets Turnover -
Management Effectiveness
Return Assets 264.86
Return On Equity -369.04
Return On Capital 38.49
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
SIGA
Siga Techn..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.